TLR2 and ovarian cancer: Kim et al. demonstrated that versican V1, a macrophage activator that acts through TLR2 and its coreceptors TLR6 and CD14, is up regulated in many human tumors including ovarian cancer and lung cancer, and enhances lung tumor metastatic growth [25].